Table 1.
Characteristics | |
---|---|
Number of subjects | 103 |
Age, mean, years (range) | 40.4 (20‐64) |
Sex, male (%) Sex, female (%) |
12 (11.7%) 91 (88.3%) |
After 1st dose After 2nd dose |
49 (47.6%) 54 (52.4%) |
Itch (%) | 70 (68.0%) |
Duration <8h (%) Duration 8‐24h (%) Duration 24‐72h (%) Duration >72h (%) |
23 (22.3%) 28 (27.1%) 38 (36.9%) 14 (13.6%) |
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.